drugset / Trial / NCT03494257

Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification

NCT03494257

Completed 62 enrolled University Hospital of Patras
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to evaluate the effect of fixed brinzolamide-brimonidine combination on intaocular pressure after uncomplicated phacoemulsification surgery. Patients scheduled for phacoemulsification will be randomly assigned to 1 of 2 groups. The treatment group will receive 1 drop of brimonidine-brinzolamide fixed combination immediately after surgery, and the control group will receive no treatment. The IOP will be measured preoperatively and at 6, 12, and 24 hours postoperatively.

Timeline

Start
2017-09-04
Primary completion
2018-03-20
Completion
2018-04-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule Topical
Comparator Brinzolamide Small molecule Topical

Indications